Operations: The company generates revenue of €4.24 million from its business services segment.

Market Cap: €9.44M

One Experience Société anonyme presents a challenging profile among European penny stocks. Despite generating €4.24 million in revenue, the company remains unprofitable with increasing net losses of €1.33 million for 2024, up from €0.706 million the previous year. Its short-term assets (€3.1M) fall short of covering its liabilities (€7.3M), yet it maintains a satisfactory net debt to equity ratio of 26.9%. The board's average tenure is experienced at 3.4 years, and while the company has reduced its debt over five years, its share price remains highly volatile with weekly volatility rising to 41%.

• Unlock comprehensive insights into our analysis of One Experience Société anonyme stock in this financial health report.

• Assess One Experience Société anonyme's previous results with our detailed historical performance reports.

Uniphar

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Uniphar plc is a diversified healthcare services company operating in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally, with a market cap of €896.83 million.

Operations: The company generates revenue through three main segments: Pharma (€658.81 million), Medtech (€267.97 million), and Supply Chain & Retail (€1.84 billion).

Market Cap: €896.83M

Uniphar plc demonstrates a solid position with its diversified revenue streams across Pharma, Medtech, and Supply Chain & Retail segments. The company has shown robust earnings growth of 43.3% over the past year, outpacing the industry average significantly. Despite this growth, Uniphar's Return on Equity is considered low at 16%. Its financial health is supported by well-covered interest payments and satisfactory net debt to equity ratio of 36.8%, although short-term liabilities exceed short-term assets by €76.9 million. Recent actions include a share buyback program worth up to €35 million aimed at reducing share capital, reflecting confidence in future performance.

• Take a closer look at Uniphar's potential here in our financial health report.

• Evaluate Uniphar's prospects by accessing our earnings growth report.

Summing It All Up

• Explore the 452 names from our European Penny Stocks screener here.

• Ready For A Different Approach? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include BIT:CAI ENXTPA:ALEXP and ISE:UPR.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com